1 |
(+)- epicatechin |
Epicatechin |
- |
- |
- |
113 1件: 113 💬 |
2 |
(+)-epicatechin |
Epicatechin |
- |
- |
- |
113 1件: 113 💬 |
3 |
(-)-epicatechin |
Epicatechin |
- |
- |
- |
086 2件: 86, 113 💬 |
4 |
12 mg/kg gsk2402968 |
- |
- |
- |
- |
113 1件: 113 💬 |
5 |
2011-2012 seasonal flu vaccine intramuscular |
- |
- |
- |
- |
003 2件: 3 , 113 💬 |
6 |
2011-2012 seasonal flu vaccine subcutaneous |
- |
- |
- |
- |
003 2件: 3 , 113 💬 |
7 |
29180.00.00, 34681.00.00, 34681.01.00, 34681.02.00 |
- |
- |
- |
- |
113 1件: 113 💬 |
8 |
3 mg/kg gsk2402968 |
- |
- |
- |
- |
113 1件: 113 💬 |
9 |
4-benzyl-2-naphthalen-1-yl-1,2,4- thiadiazolidine-3,5-dione |
- |
- |
- |
- |
113 1件: 113 💬 |
10 |
4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione |
- |
- |
- |
- |
113 1件: 113 💬 |
11 |
5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole |
- |
- |
- |
- |
113 1件: 113 💬 |
12 |
6 mg/kg gsk2402968 |
- |
- |
- |
- |
113 1件: 113 💬 |
13 |
750 mg metformin and 7.5 g l-citrulline daily p.o. |
Citrulline |
3件: D00944 D00944, D04966 D04966, D07706 D07706 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 1件: 113 💬 |
14 |
9 mg/kg gsk2402968 |
- |
- |
- |
- |
113 1件: 113 💬 |
15 |
[wve-210201] |
- |
- |
- |
- |
113 1件: 113 💬 |
16 |
Aav1-gamma-sarcoglycan vector injection |
- |
- |
- |
- |
113 1件: 113 💬 |
17 |
Ace-031 (extension of cohort 1 from core study, a031-03) |
- |
- |
- |
- |
113 1件: 113 💬 |
18 |
Ace-031 (extension of cohort 2 from core study, a031-03) |
- |
- |
- |
- |
113 1件: 113 💬 |
19 |
Ace-031 (extension of cohort 3 from core study, a031-03) |
- |
- |
- |
- |
113 1件: 113 💬 |
20 |
Ace-031 0.5 mg/kg q4wk |
- |
- |
- |
- |
113 1件: 113 💬 |
21 |
Ace-031 1.0 mg/kg q2wk |
- |
- |
- |
- |
113 1件: 113 💬 |
22 |
Ace-083 |
- |
- |
- |
- |
010 2件: 10, 113 💬 |
23 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
24 |
Actonel once a week 5mg film coated tablets |
- |
- |
- |
- |
113 1件: 113 💬 |
25 |
Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene |
- |
- |
- |
- |
113 1件: 113 💬 |
26 |
Albuterol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 8件: 12, 13, 86, 89, 113, 231, 256, 299 💬 |
27 |
Allogeneic cardiosphere-derived cells (cap-1002) |
CAP-1002 |
- |
- |
- |
113 1件: 113 💬 |
28 |
Anti-myostati |
- |
- |
- |
- |
113 1件: 113 💬 |
29 |
Anti-myostatin adnectin |
- |
- |
- |
- |
113 1件: 113 💬 |
30 |
Arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
046 9件: 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
31 |
Asp0367 |
- |
- |
- |
- |
113 1件: 113 💬 |
32 |
Aspirin |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 11件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
33 |
Ataluren |
Ataluren |
1件: D09323 D09323 💬 |
- |
- |
019 6件: 19, 113, 140, 246, 299, 329 💬 |
34 |
Ataluren 1000 mg |
Ataluren |
1件: D09323 D09323 💬 |
- |
- |
113 1件: 113 💬 |
35 |
Ataluren 125 mg |
Ataluren |
1件: D09323 D09323 💬 |
- |
- |
113 1件: 113 💬 |
36 |
Ataluren 250 mg |
Ataluren |
1件: D09323 D09323 💬 |
- |
- |
113 1件: 113 💬 |
37 |
Atyr1940 |
- |
- |
- |
- |
113 1件: 113 💬 |
38 |
Autologous bone marrow mononuclear cell transplantation |
- |
- |
- |
- |
113 1件: 113 💬 |
39 |
Avi-4658 |
- |
- |
- |
- |
113 1件: 113 💬 |
40 |
Avi-4658 (eteplirsen) |
Eteplirsen |
1件: D09900 D09900 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
41 |
Avi-4658 (pmo) |
- |
- |
- |
- |
113 1件: 113 💬 |
42 |
Avi-4658 for injection |
- |
- |
- |
- |
113 1件: 113 💬 |
43 |
Balance |
Isoxaflutole |
- |
- |
- |
005 9件: 5 , 6 , 13, 46, 81, 113, 122, 149, 299 💬 |
44 |
Behavioral: in-home exercise training |
- |
- |
- |
- |
113 1件: 113 💬 |
45 |
Behavioral: regular exercise |
- |
- |
- |
- |
113 1件: 113 💬 |
46 |
Bio101 |
- |
- |
- |
- |
113 1件: 113 💬 |
47 |
Biological: umbilical cord based allogenic mesenchymal stem cell |
- |
- |
- |
- |
113 1件: 113 💬 |
48 |
Bisoprolol |
Bisoprolol |
2件: D00634 D00634, D02342 D02342 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 3件: 67, 86, 113 💬 |
49 |
Bisoprolol fumarate |
Bisoprolol |
2件: D00634 D00634, D02342 D02342 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
113 1件: 113 💬 |
50 |
Bisphosphonate treatment |
- |
- |
- |
- |
113 2件: 113, 299 💬 |
51 |
Blood test |
- |
- |
- |
- |
036 5件: 36, 86, 113, 162, 299 💬 |
52 |
Bls-m22 |
- |
- |
- |
- |
113 1件: 113 💬 |
53 |
Bmn 044 |
- |
- |
- |
- |
113 1件: 113 💬 |
54 |
Bmn 044 iv 6 mg/kg |
- |
- |
- |
- |
113 1件: 113 💬 |
55 |
Bmn 044 iv 9 mg/kg |
- |
- |
- |
- |
113 1件: 113 💬 |
56 |
Bmn 044 sc 6 mg/kg |
- |
- |
- |
- |
113 1件: 113 💬 |
57 |
Bmn 045 |
- |
- |
- |
- |
113 1件: 113 💬 |
58 |
Bmn 053 |
- |
- |
- |
- |
113 1件: 113 💬 |
59 |
Bmn053 |
- |
- |
- |
- |
113 1件: 113 💬 |
60 |
Bms-986089 |
- |
- |
- |
- |
113 1件: 113 💬 |
61 |
Bms-986089-01 (ro7239361) , anti-myostatin |
- |
- |
- |
- |
113 1件: 113 💬 |
62 |
Bms-986089-01 (ro7239361) injections, 15 mg/syringe (21.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
63 |
Bms-986089-01 (ro7239361) injections, 35 mg/syringe (50 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
64 |
Bms-986089-01 (ro7239361) injections, 50 mg/syringe (71.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
65 |
Bms-986089-01 (ro7239361) injections, 7.5 mg/syringe (10.7 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
66 |
Bms-986089-01 (ro7239361), anti-myostatin |
- |
- |
- |
- |
113 1件: 113 💬 |
67 |
Bms-986089-01 injections, 15 mg/syringe (21.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
68 |
Bms-986089-01 injections, 35 mg/syringe (50 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
69 |
Bms-986089-01 injections, 50 mg/syringe (71.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
70 |
Bms-986089-01 injections, 7.5 mg/syringe (10.7 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
71 |
Bms-986089-01, anti-myostatin |
- |
- |
- |
- |
113 1件: 113 💬 |
72 |
Botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 10件: 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
73 |
Cabaletta |
Trehalose |
- |
- |
- |
018 2件: 18, 113 💬 |
74 |
Calcichew d3 forte |
- |
- |
- |
- |
113 1件: 113 💬 |
75 |
Calcifediol |
Calcifediol |
1件: D00122 D00122 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
113 1件: 113 💬 |
76 |
Canakinumab |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 |
77 |
Canakinumab injection [ilaris] |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
113 1件: 113 💬 |
78 |
Cap-1002 |
CAP-1002 |
- |
- |
- |
113 1件: 113 💬 |
79 |
Cardicor |
- |
- |
- |
- |
113 1件: 113 💬 |
80 |
Cardicor (merck brand) |
- |
- |
- |
- |
113 1件: 113 💬 |
81 |
Cardiovascular profile |
- |
- |
- |
- |
113 1件: 113 💬 |
82 |
Carvedilol |
Carvedilol |
2件: D00255 D00255, D03415 D03415 💬 |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 5件: 6 , 57, 86, 113, 210 💬 |
83 |
Casimersen |
Casimersen |
1件: D11988 D11988 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
84 |
Cat-1004 |
- |
- |
- |
- |
113 1件: 113 💬 |
85 |
Chronic corticosteroid therapy |
- |
- |
- |
- |
113 1件: 113 💬 |
86 |
Cialis 10 mg film-coated tablets |
- |
- |
- |
- |
086 2件: 86, 113 💬 |
87 |
Cialis 2.5 mg film-coated tablets |
- |
- |
- |
- |
086 2件: 86, 113 💬 |
88 |
Cialis 20 mg film-coated tablets |
- |
- |
- |
- |
086 2件: 86, 113 💬 |
89 |
Cialis 5 mg film-coated tablets |
- |
- |
- |
- |
086 2件: 86, 113 💬 |
90 |
Citrulline |
Citrulline |
1件: D07706 D07706 💬 |
- |
- |
086 2件: 86, 113 💬 |
91 |
Coenzyme q10 |
Ubidecarenone |
1件: D01065 D01065 💬 |
- |
- |
002 12件: 2 , 5 , 6 , 8 , 10, 18, 46, 57, 113, 193, 214, 215 💬 |
92 |
Coenzyme q10 and lisinopril |
Lisinopril |
3件: D00362 D00362, D01065 D01065, D08131 D08131 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
113 1件: 113 💬 |
93 |
Cosyntropin |
Tetracosactide |
1件: D00284 D00284 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
083 3件: 83, 113, 145 💬 |
94 |
Cosyntropin acetate |
Acetate |
1件: D00284 D00284 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
113 1件: 113 💬 |
95 |
Cr13c |
- |
- |
- |
- |
113 1件: 113 💬 |
96 |
Crd007 |
- |
- |
- |
- |
113 1件: 113 💬 |
97 |
Creatine |
Creatine |
- |
- |
- |
001 12件: 1 , 2 , 5 , 6 , 8 , 13, 46, 49, 50, 113, 156, 201 💬 |
98 |
Creatine monohydrate |
Creatine |
- |
- |
- |
002 4件: 2 , 8 , 113, 156 💬 |
99 |
Creatine-13c |
Creatine |
- |
- |
- |
113 1件: 113 💬 |
100 |
Cyclosporin |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
038 17件: 38, 46, 49, 50, 53, 56, 60, 62, 63, 93, 95, 97, 113, 164, 222, 274, 326 💬 |
101 |
Cyclosporin a |
Cyclosporine |
1件: D00184 D00184 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
046 11件: 46, 49, 53, 56, 60, 62, 63, 93, 95, 113, 164 💬 |
102 |
Decortin |
- |
- |
- |
- |
046 2件: 46, 113 💬 |
103 |
Deflan*10cpr 6mg |
- |
- |
- |
- |
113 1件: 113 💬 |
104 |
Deflazacort |
Deflazacort |
1件: D03671 D03671 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
030 2件: 30, 113 💬 |
105 |
Deflazacort 6 mg tablets |
Deflazacort |
1件: D03671 D03671 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
106 |
Dehydroepiandrosterone |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 5件: 49, 53, 83, 96, 113 💬 |
107 |
Dehydroepiandrosterone 100 and 400 mg |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
113 1件: 113 💬 |
108 |
Deltacortene*20cpr 5mg |
- |
- |
- |
- |
049 3件: 49, 97, 113 💬 |
109 |
Device: activity monitor |
Methamidophos |
- |
- |
- |
113 1件: 113 💬 |
110 |
Dexmedetomidine |
Dexmedetomidine |
2件: D00514 D00514, D01205 D01205 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 12件: 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
111 |
Dha |
- |
- |
- |
- |
006 8件: 6 , 46, 48, 49, 94, 113, 299, 301 💬 |
112 |
Diagnostic test: 30 seconds sit to stand test |
- |
- |
- |
- |
113 1件: 113 💬 |
113 |
Diagnostic test: beck depression inventory |
- |
- |
- |
- |
113 1件: 113 💬 |
114 |
Diagnostic test: berg balance scale |
Isoxaflutole |
- |
- |
- |
113 1件: 113 💬 |
115 |
Diagnostic test: brief pain inventory short-form |
- |
- |
- |
- |
113 1件: 113 💬 |
116 |
Diagnostic test: dm1-activc |
- |
- |
- |
- |
113 1件: 113 💬 |
117 |
Diagnostic test: fatigue and daytime sleepiness scale |
- |
- |
- |
- |
113 1件: 113 💬 |
118 |
Diagnostic test: functional index-2 |
- |
- |
- |
- |
113 1件: 113 💬 |
119 |
Diagnostic test: gsgc |
- |
- |
- |
- |
113 1件: 113 💬 |
120 |
Diagnostic test: hand opening time |
- |
- |
- |
- |
113 1件: 113 💬 |
121 |
Diagnostic test: manual muscle testing |
- |
- |
- |
- |
113 1件: 113 💬 |
122 |
Diagnostic test: mcgill pain questionnaire |
- |
- |
- |
- |
113 1件: 113 💬 |
123 |
Diagnostic test: myotonia (from individualised neuromuscular quality of life questionnaire) |
- |
- |
- |
- |
113 1件: 113 💬 |
124 |
Diagnostic test: myotonia behaviour scale |
- |
- |
- |
- |
113 1件: 113 💬 |
125 |
Diagnostic test: pressure pain threshold |
- |
- |
- |
- |
113 1件: 113 💬 |
126 |
Diagnostic test: quantitative muscle testing |
- |
- |
- |
- |
113 1件: 113 💬 |
127 |
Diagnostic test: quick motor function test |
- |
- |
- |
- |
113 1件: 113 💬 |
128 |
Diagnostic test: r-pact |
- |
- |
- |
- |
113 1件: 113 💬 |
129 |
Diagnostic test: scale for assessment and rating of ataxia |
- |
- |
- |
- |
113 1件: 113 💬 |
130 |
Diagnostic test: six minute walking test |
- |
- |
- |
- |
113 1件: 113 💬 |
131 |
Dilatrend |
- |
- |
- |
- |
113 1件: 113 💬 |
132 |
Dosing extension |
- |
- |
- |
- |
113 1件: 113 💬 |
133 |
Drisapersen |
Drisapersen |
1件: D10114 D10114 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
134 |
Drisapersen sodium |
Drisapersen |
1件: D10114 D10114 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
135 |
Ds-5141b |
- |
- |
- |
- |
113 1件: 113 💬 |
136 |
Edasalonexent |
Edasalonexent |
- |
- |
- |
113 1件: 113 💬 |
137 |
Edg-5506 |
- |
- |
- |
- |
113 1件: 113 💬 |
138 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
139 |
Emd 87580 |
- |
- |
- |
- |
113 1件: 113 💬 |
140 |
Emea/h/c/000638 |
- |
- |
- |
- |
113 1件: 113 💬 |
141 |
Emflaza® (deflazacort) |
Deflazacort |
1件: D03671 D03671 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
142 |
Enahexal |
- |
- |
- |
- |
113 1件: 113 💬 |
143 |
Enahexal®, 10mg |
- |
- |
- |
- |
113 1件: 113 💬 |
144 |
Enalapril |
Enalapril |
2件: D00621 D00621, D07892 D07892 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 66, 113, 210, 222, 223 💬 |
145 |
Enalhexal®, 5 mg |
- |
- |
- |
- |
113 1件: 113 💬 |
146 |
Epa |
- |
- |
- |
- |
008 6件: 8 , 46, 48, 49, 113, 301 💬 |
147 |
Epa and dha |
- |
- |
- |
- |
113 1件: 113 💬 |
148 |
Epicatechin |
Epicatechin |
- |
- |
- |
086 2件: 86, 113 💬 |
149 |
Epigallocatechin |
Epigallocatechin |
- |
- |
- |
008 5件: 8 , 13, 28, 85, 113 💬 |
150 |
Epigallocatechin-gallate |
Epigallocatechin |
- |
- |
- |
113 1件: 113 💬 |
151 |
Eplerenone |
Eplerenone |
1件: D01115 D01115 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
075 4件: 75, 113, 210, 215 💬 |
152 |
Erx-963 |
- |
- |
- |
- |
113 1件: 113 💬 |
153 |
Eteplirsen |
Eteplirsen |
1件: D09900 D09900 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
154 |
Eteplirsen injection |
Eteplirsen |
1件: D09900 D09900 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
155 |
Eucardic |
- |
- |
- |
- |
113 1件: 113 💬 |
156 |
Ev substance code: sub188638 |
- |
- |
- |
- |
113 1件: 113 💬 |
157 |
Exondys 51 |
- |
- |
- |
- |
113 1件: 113 💬 |
158 |
Exondys 51™ |
- |
- |
- |
- |
113 1件: 113 💬 |
159 |
Ezutromid |
Ezutromid |
- |
- |
- |
113 1件: 113 💬 |
160 |
Fg-3019 |
- |
- |
- |
- |
085 3件: 85, 113, 222 💬 |
161 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
162 |
Flavocoxid |
- |
- |
- |
- |
113 1件: 113 💬 |
163 |
Ftx-1821 |
- |
- |
- |
- |
113 1件: 113 💬 |
164 |
Genetic: rna extraction |
- |
- |
- |
- |
113 1件: 113 💬 |
165 |
Gentamicin |
Gentamicin |
2件: D01063 D01063, D08013 D08013 💬 |
- |
- |
036 3件: 36, 113, 299 💬 |
166 |
Gentamicin infusions twice a week for six months |
Gentamicin |
2件: D01063 D01063, D08013 D08013 💬 |
- |
- |
113 1件: 113 💬 |
167 |
Givinostat |
Givinostat |
- |
- |
- |
113 1件: 113 💬 |
168 |
Givinostat (hydrochloride monohydrate) |
Givinostat |
- |
- |
- |
113 1件: 113 💬 |
169 |
Givinostat (hyrochloride monohydrate) |
Givinostat |
- |
- |
- |
113 1件: 113 💬 |
170 |
Givinostat (idrocloruro monoidrato) |
Givinostat |
- |
- |
- |
113 1件: 113 💬 |
171 |
Glutamine |
L-Glutamine |
1件: D00015 D00015 💬 |
- |
- |
087 7件: 87, 89, 96, 97, 113, 245, 299 💬 |
172 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
173 |
Golodirsen |
Golodirsen |
1件: D11707 D11707 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
174 |
Granulocyte colony-stimulating factor (filgrastim) |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
113 1件: 113 💬 |
175 |
Gsk2402968 |
- |
- |
- |
- |
113 1件: 113 💬 |
176 |
Gsk2402968 3mg/kg/week |
- |
- |
- |
- |
113 1件: 113 💬 |
177 |
Gsk2402968 6 mg/kg/week |
- |
- |
- |
- |
113 1件: 113 💬 |
178 |
Gsk2402968 6mg/kg/week |
- |
- |
- |
- |
113 1件: 113 💬 |
179 |
Guanidine |
Guanidine |
1件: D02437 D02437 💬 |
- |
- |
113 1件: 113 💬 |
180 |
H44aon188 |
- |
- |
- |
- |
113 1件: 113 💬 |
181 |
H51aon23 |
- |
- |
- |
- |
113 1件: 113 💬 |
182 |
Haemostasis tests |
- |
- |
- |
- |
113 1件: 113 💬 |
183 |
Hidroferol |
- |
- |
- |
- |
113 1件: 113 💬 |
184 |
Hidroferol® |
- |
- |
- |
- |
113 1件: 113 💬 |
185 |
Hla-identical allogeneic mesoangioblasts |
- |
- |
- |
- |
113 1件: 113 💬 |
186 |
Hmabs |
- |
- |
- |
- |
113 1件: 113 💬 |
187 |
Hormonal profile |
- |
- |
- |
- |
113 1件: 113 💬 |
188 |
Ht-100 |
- |
- |
- |
- |
113 1件: 113 💬 |
189 |
Human umbilical cord mesenchymal stem cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
013 2件: 13, 113 💬 |
190 |
Ibuprofen |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 6件: 13, 46, 65, 113, 271, 299 💬 |
191 |
Ibuprofen 200mg |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 1件: 113 💬 |
192 |
Idebenone |
Idebenone |
1件: D01750 D01750 💬 |
- |
- |
006 5件: 6 , 13, 18, 113, 302 💬 |
193 |
Idebenone 150 mg film-coated tablets |
Idebenone |
1件: D01750 D01750 💬 |
- |
- |
113 1件: 113 💬 |
194 |
Ifetroban |
Ifetroban |
1件: D04500 D04500 💬 |
TBXA2R 1件: TBXA2R 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation |
051 3件: 51, 86, 113 💬 |
195 |
Igf-1 |
- |
- |
- |
- |
113 1件: 113 💬 |
196 |
Inflammatory profile |
- |
- |
- |
- |
113 1件: 113 💬 |
197 |
Ionis-dmpkrx |
- |
- |
- |
- |
113 1件: 113 💬 |
198 |
Isosorbide |
Isosorbide |
1件: D00347 D00347 💬 |
- |
- |
113 1件: 113 💬 |
199 |
Isosorbide dinitrate |
Isosorbide |
2件: D00347 D00347, D00516 D00516 💬 |
- |
- |
113 1件: 113 💬 |
200 |
Isosorbide dinitrate 20 mg |
Isosorbide |
2件: D00347 D00347, D00516 D00516 💬 |
- |
- |
113 1件: 113 💬 |
201 |
Isosorbide dinitrate 40 mg |
Isosorbide |
2件: D00347 D00347, D00516 D00516 💬 |
- |
- |
113 1件: 113 💬 |
202 |
Isosorbide dinitrate 60 mg |
Isosorbide |
2件: D00347 D00347, D00516 D00516 💬 |
- |
- |
113 1件: 113 💬 |
203 |
Isosorbide dinitrate 80 mg |
Isosorbide |
2件: D00347 D00347, D00516 D00516 💬 |
- |
- |
113 1件: 113 💬 |
204 |
Itf2357 |
- |
- |
- |
- |
096 4件: 96, 107, 113, 267 💬 |
205 |
Ketamine |
Ketamine |
2件: D00711 D00711, D08098 D08098 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 5件: 13, 70, 113, 156, 215 💬 |
206 |
L-arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
046 3件: 46, 113, 299 💬 |
207 |
L-citrulline and metformin & l-citrulline |
Citrulline |
3件: D00944 D00944, D04966 D04966, D07706 D07706 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 1件: 113 💬 |
208 |
L-glutamine |
L-Glutamine |
1件: D00015 D00015 💬 |
- |
- |
113 2件: 113, 299 💬 |
209 |
Lentiviral vector trans-skip gene modified autologous mesoangioblasts |
- |
- |
- |
- |
113 1件: 113 💬 |
210 |
Lisinopril |
Lisinopril |
2件: D00362 D00362, D08131 D08131 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 7件: 19, 46, 49, 66, 67, 113, 222 💬 |
211 |
Lonafarnib |
Lonafarnib |
1件: D04768 D04768 💬 |
FNTA 2件: FNTA, FNTB 💬 |
Terpenoid backbone biosynthesis 1件: Terpenoid backbone biosynthesis |
113 2件: 113, 333 💬 |
212 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
213 |
Losmapimod |
Losmapimod |
1件: D09639 D09639 💬 |
MAPK11 4件: MAPK11, MAPK12, MAPK13, MAPK14 💬 |
AGE-RAGE signaling pathway in diabetic complications 58件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection |
113 2件: 113, 222 💬 |
214 |
Metabolic profile |
- |
- |
- |
- |
113 1件: 113 💬 |
215 |
Metformin |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
002 21件: 2 , 6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬 |
216 |
Metformin 500mg |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 1件: 113 💬 |
217 |
Metformin and metformin & l-citrulline |
Citrulline |
3件: D00944 D00944, D04966 D04966, D07706 D07706 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 1件: 113 💬 |
218 |
Metformina |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
067 2件: 67, 113 💬 |
219 |
Metformina - 500 30 compresse 500 mg |
Metformin |
2件: D00944 D00944, D04966 D04966 💬 |
PRKAA1 2件: PRKAA1, PRKAA2 💬 |
AMPK signaling pathway 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway |
113 1件: 113 💬 |
220 |
Methylphenidate |
Methylphenidate |
2件: D01296 D01296, D04999 D04999 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 7件: 6 , 13, 34, 84, 113, 179, 206 💬 |
221 |
Metohexal® succ ® 23,75 mg retardtabletten |
- |
- |
- |
- |
113 1件: 113 💬 |
222 |
Metohexal® succ ® 47,5 mg retardtabletten |
- |
- |
- |
- |
113 1件: 113 💬 |
223 |
Metohexal® succ ® 95 mg retardtabletten |
- |
- |
- |
- |
113 1件: 113 💬 |
224 |
Metoprolol |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 6件: 17, 57, 58, 113, 193, 226 💬 |
225 |
Metoprolol succinate |
Metoprolol |
3件: D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 4件: 57, 58, 113, 193 💬 |
226 |
Mexiletine |
Mexiletine |
2件: D00639 D00639, D08215 D08215 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
001 5件: 1 , 2 , 10, 113, 114 💬 |
227 |
Mnk-1411 |
- |
- |
- |
- |
113 1件: 113 💬 |
228 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
229 |
Monocytes and megacaryocytes culture and rna extraction |
- |
- |
- |
- |
113 1件: 113 💬 |
230 |
Myo-029 |
MYO-029 |
- |
- |
- |
113 1件: 113 💬 |
231 |
Myoblast autologous graft |
- |
- |
- |
- |
113 1件: 113 💬 |
232 |
Myoblast transplantation |
- |
- |
- |
- |
113 1件: 113 💬 |
233 |
Myoblastes autologues |
- |
- |
- |
- |
113 1件: 113 💬 |
234 |
Myodm |
- |
- |
- |
- |
113 1件: 113 💬 |
235 |
N(4,5bis methanesulfonyl2methylbenzoyl) guanidine hydrochloride monohydrate |
Guanidine |
1件: D02437 D02437 💬 |
- |
- |
113 1件: 113 💬 |
236 |
N-(4,5-bis methanesulfonyl-2-methyl-benzoyl)guanidine hydrochloride monohydrate |
Guanidine |
1件: D02437 D02437 💬 |
- |
- |
113 1件: 113 💬 |
237 |
Nanosuspension) |
- |
- |
- |
- |
113 1件: 113 💬 |
238 |
Nebivolol |
Nebivolol |
1件: D05127 D05127 💬 |
ADRB1 1件: ADRB1 💬 |
Adrenergic signaling in cardiomyocytes 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 3件: 17, 113, 167 💬 |
239 |
Needle biopsy of the vastus lateralis muscle |
- |
- |
- |
- |
113 1件: 113 💬 |
240 |
Nitrate |
Nitrate |
1件: D02313 D02313 💬 |
- |
- |
058 3件: 58, 113, 299 💬 |
241 |
Npc-14 |
- |
- |
- |
- |
113 1件: 113 💬 |
242 |
Ns-065/ncnp-01 |
- |
- |
- |
- |
113 1件: 113 💬 |
243 |
Ns-089/ncnp-02 |
- |
- |
- |
- |
113 1件: 113 💬 |
244 |
Nébivolol |
- |
- |
- |
- |
113 1件: 113 💬 |
245 |
Oligomero morfolino fosforodiamidato per skipping dell’esone 45 |
- |
- |
- |
- |
113 1件: 113 💬 |
246 |
Oligomero morfolino fosforodiamidato per skipping dell’esone 53 |
- |
- |
- |
- |
113 1件: 113 💬 |
247 |
Omigapil |
Omigapil |
- |
- |
- |
113 1件: 113 💬 |
248 |
Other: beetroot juice extract |
- |
- |
- |
- |
113 1件: 113 💬 |
249 |
Other: dystrophin levels |
- |
- |
- |
- |
113 1件: 113 💬 |
250 |
Other: echocardiogram |
- |
- |
- |
- |
113 1件: 113 💬 |
251 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
6件: D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 1件: 113 💬 |
252 |
Other: magnetic resonance imaging (mri) |
- |
- |
- |
- |
113 1件: 113 💬 |
253 |
Other: metabolic exercise testing using stationary bicycle |
- |
- |
- |
- |
113 1件: 113 💬 |
254 |
Other: pulmonary function testing (pft) |
- |
- |
- |
- |
113 1件: 113 💬 |
255 |
Other: standard steroid treatment |
- |
- |
- |
- |
113 1件: 113 💬 |
256 |
Oxatomide |
Oxatomide |
1件: D01773 D01773 💬 |
ALOX5 1件: ALOX5 💬 |
Arachidonic acid metabolism 6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis |
113 1件: 113 💬 |
257 |
Oxatomide (tinset) |
Oxatomide |
1件: D01773 D01773 💬 |
ALOX5 1件: ALOX5 💬 |
Arachidonic acid metabolism 6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis |
113 1件: 113 💬 |
258 |
P-188 nf |
- |
- |
- |
- |
113 1件: 113 💬 |
259 |
Pamrevlumab |
Pamrevlumab |
1件: D10969 D10969 💬 |
CCN2 1件: CCN2 💬 |
Apelin signaling pathway 2件: Apelin signaling pathway, Hippo signaling pathway |
085 2件: 85, 113 💬 |
260 |
Pamrevlumab (fg-3019) |
Pamrevlumab |
1件: D10969 D10969 💬 |
CCN2 1件: CCN2 💬 |
Apelin signaling pathway 2件: Apelin signaling pathway, Hippo signaling pathway |
113 1件: 113 💬 |
261 |
Pb1046 injection |
- |
- |
- |
- |
113 1件: 113 💬 |
262 |
Pemirolast |
Pemirolast |
2件: D01088 D01088, D07476 D07476 💬 |
- |
- |
113 1件: 113 💬 |
263 |
Pending |
- |
- |
- |
- |
013 6件: 13, 19, 96, 97, 113, 302 💬 |
264 |
Pentoxifylline |
Pentoxifylline |
1件: D00501 D00501 💬 |
- |
- |
026 10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
265 |
Peptide-conjugated phosphorodiamidate morpholino oligomer for exon 51 skipping |
- |
- |
- |
- |
113 1件: 113 💬 |
266 |
Perindopril |
Perindopril |
2件: D00624 D00624, D03753 D03753 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
113 3件: 113, 167, 222 💬 |
267 |
Perindopril 2mg tablets |
Perindopril |
2件: D00624 D00624, D03753 D03753 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
113 1件: 113 💬 |
268 |
Pf-06252616 |
Domagrozumab |
1件: D11047 D11047 💬 |
MSTN 1件: MSTN 💬 |
Cytokine-cytokine receptor interaction 1件: Cytokine-cytokine receptor interaction |
113 1件: 113 💬 |
269 |
Pf-06939926 |
- |
- |
- |
- |
113 1件: 113 💬 |
270 |
Pft |
- |
- |
- |
- |
089 3件: 89, 113, 299 💬 |
271 |
Phosphorodiamidate morpholino oligomer |
- |
- |
- |
- |
113 1件: 113 💬 |
272 |
Phosphorodiamidate morpholino oligomer for exon 45 skipping |
- |
- |
- |
- |
113 1件: 113 💬 |
273 |
Phosphorodiamidate morpholino oligomer for exon 53 skipping |
- |
- |
- |
- |
113 1件: 113 💬 |
274 |
Powder for oral suspension) |
- |
- |
- |
- |
113 1件: 113 💬 |
275 |
Prd2175434 |
- |
- |
- |
- |
113 1件: 113 💬 |
276 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
277 |
Prednison |
- |
- |
- |
- |
046 3件: 46, 84, 113 💬 |
278 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
279 |
Prednisone 5 mg tablets |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
280 |
Pro044 |
- |
- |
- |
- |
113 1件: 113 💬 |
281 |
Pro044 iv |
- |
- |
- |
- |
113 1件: 113 💬 |
282 |
Pro044 iv 6 mg/kg |
- |
- |
- |
- |
113 1件: 113 💬 |
283 |
Pro044 iv 9 mg/kg |
- |
- |
- |
- |
113 1件: 113 💬 |
284 |
Pro044 sc |
- |
- |
- |
- |
113 1件: 113 💬 |
285 |
Pro044 sc 6 mg/kg |
- |
- |
- |
- |
113 1件: 113 💬 |
286 |
Pro045 |
- |
- |
- |
- |
113 1件: 113 💬 |
287 |
Pro045, 0.15 mg/kg/week |
- |
- |
- |
- |
113 1件: 113 💬 |
288 |
Pro045, 1.0 mg/kg/week |
- |
- |
- |
- |
113 1件: 113 💬 |
289 |
Pro045, 3.0 mg/kg/week |
- |
- |
- |
- |
113 1件: 113 💬 |
290 |
Pro045, 6.0 mg/kg/week |
- |
- |
- |
- |
113 1件: 113 💬 |
291 |
Pro045, 9.0 mg/kg/week |
- |
- |
- |
- |
113 1件: 113 💬 |
292 |
Pro045, selected dose |
- |
- |
- |
- |
113 1件: 113 💬 |
293 |
Pro051 |
- |
- |
- |
- |
113 1件: 113 💬 |
294 |
Pro053 |
- |
- |
- |
- |
113 1件: 113 💬 |
295 |
Procedure: increased exercise intensity |
- |
- |
- |
- |
113 1件: 113 💬 |
296 |
Procedure: saline injection |
- |
- |
- |
- |
113 1件: 113 💬 |
297 |
Procedure: taking of blood |
- |
- |
- |
- |
113 1件: 113 💬 |
298 |
Protein-carbohydrate supplementation |
- |
- |
- |
- |
113 1件: 113 💬 |
299 |
Ps188 |
- |
- |
- |
- |
113 1件: 113 💬 |
300 |
Ps188 (company code) |
- |
- |
- |
- |
113 1件: 113 💬 |
301 |
Ps220 |
- |
- |
- |
- |
113 1件: 113 💬 |
302 |
Ps524 |
- |
- |
- |
- |
113 1件: 113 💬 |
303 |
Ptc0161480, ptc124 compound 1a, rps2505, ptc-c124, 291844 |
- |
- |
- |
- |
113 1件: 113 💬 |
304 |
Ptc124 |
- |
- |
- |
- |
019 4件: 19, 113, 246, 299 💬 |
305 |
Raav1.cmv.hufollistatin344 |
- |
- |
- |
- |
015 2件: 15, 113 💬 |
306 |
Raav1.cmv.hufollistin344 |
- |
- |
- |
- |
113 1件: 113 💬 |
307 |
Raav2.5-cmv-minidystrophin (d3990) |
- |
- |
- |
- |
113 1件: 113 💬 |
308 |
Raav9-ck8-h-µd5 |
- |
- |
- |
- |
113 1件: 113 💬 |
309 |
Raavrh74.mck.galgt2 |
- |
- |
- |
- |
113 1件: 113 💬 |
310 |
Raavrh74.mck.micro-dystrophin |
- |
- |
- |
- |
113 1件: 113 💬 |
311 |
Ramipril |
Ramipril |
1件: D00421 D00421 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 7件: 46, 49, 66, 67, 113, 218, 257 💬 |
312 |
Ranolazine |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
002 6件: 2 , 58, 86, 96, 113, 114 💬 |
313 |
Raxone |
- |
- |
- |
- |
113 1件: 113 💬 |
314 |
Raxone - 150 mg- compresse rivestite con film- uso orale- flacone (hdpe)- 180 compresse |
- |
- |
- |
- |
113 1件: 113 💬 |
315 |
Recombinant human anti-gdf-8 antibody |
- |
- |
- |
- |
113 1件: 113 💬 |
316 |
Regimen selection phase group 1 (completed) |
- |
- |
- |
- |
113 1件: 113 💬 |
317 |
Regimen selection phase group 2 |
- |
- |
- |
- |
113 1件: 113 💬 |
318 |
Regimen selection phase group 3 |
- |
- |
- |
- |
113 1件: 113 💬 |
319 |
Resveratrol |
Resveratrol |
- |
- |
- |
002 6件: 2 , 8 , 18, 89, 113, 299 💬 |
320 |
Revatio |
- |
- |
- |
- |
085 3件: 85, 86, 113 💬 |
321 |
Rhigf-i/rhigfbp-3 |
rhIGFBP-3 |
- |
- |
- |
113 1件: 113 💬 |
322 |
Rhigfbp-3 |
rhIGFBP-3 |
- |
- |
- |
113 2件: 113, 195 💬 |
323 |
Rimeporide |
Rimeporide |
- |
- |
- |
113 1件: 113 💬 |
324 |
Risedronate |
Risedronic acid |
3件: D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 6件: 46, 50, 66, 96, 113, 274 💬 |
325 |
Risedronate sodium |
Risedronic acid |
3件: D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
050 3件: 50, 113, 274 💬 |
326 |
Ro7239361 |
- |
- |
- |
- |
113 1件: 113 💬 |
327 |
Ro7239361 (bms-986089) |
- |
- |
- |
- |
113 1件: 113 💬 |
328 |
Ro7239361 injections, 15 mg/syringe (21.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
329 |
Ro7239361 injections, 35 mg/syringe (50 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
330 |
Ro7239361 injections, 50 mg/syringe (71.4 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
331 |
Ro7239361 injections, 7.5 mg/syringe (10.7 mg/ml) |
- |
- |
- |
- |
113 1件: 113 💬 |
332 |
Sandimmun optoral |
- |
- |
- |
- |
053 2件: 53, 113 💬 |
333 |
Scaav9.u7.acca |
- |
- |
- |
- |
113 1件: 113 💬 |
334 |
Scaavrh74.tmck.hsgca |
- |
- |
- |
- |
113 1件: 113 💬 |
335 |
Sgt-001 |
- |
- |
- |
- |
113 1件: 113 💬 |
336 |
Sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
337 |
Sleep parameters |
- |
- |
- |
- |
113 1件: 113 💬 |
338 |
Smt c1100 |
- |
- |
- |
- |
113 1件: 113 💬 |
339 |
Smt c1100 (f5 |
- |
- |
- |
- |
113 1件: 113 💬 |
340 |
Smt c1100 (f5) |
- |
- |
- |
- |
113 1件: 113 💬 |
341 |
Smt c1100 (f6 |
- |
- |
- |
- |
113 1件: 113 💬 |
342 |
Smt c1100 (f6) |
- |
- |
- |
- |
113 1件: 113 💬 |
343 |
Snt-mc17 |
- |
- |
- |
- |
113 1件: 113 💬 |
344 |
Sodium nitrate |
Nitrate |
1件: D02313 D02313 💬 |
- |
- |
058 2件: 58, 113 💬 |
345 |
Sodium nitrate - double dose |
Nitrate |
1件: D02313 D02313 💬 |
- |
- |
113 1件: 113 💬 |
346 |
Somatokine/iplex |
- |
- |
- |
- |
113 1件: 113 💬 |
347 |
Somatropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 16件: 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
348 |
Spironolactone |
Spironolactone |
1件: D00443 D00443 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
058 7件: 58, 67, 86, 113, 210, 218, 225 💬 |
349 |
Srp-4045 |
- |
- |
- |
- |
113 1件: 113 💬 |
350 |
Srp-4053 |
- |
- |
- |
- |
113 1件: 113 💬 |
351 |
Srp-5051 |
- |
- |
- |
- |
113 1件: 113 💬 |
352 |
Stem cell |
- |
- |
- |
- |
002 2件: 2 , 113 💬 |
353 |
Stem cells |
- |
- |
- |
- |
002 4件: 2 , 4 , 96, 113 💬 |
354 |
Sunphenon |
- |
- |
- |
- |
013 2件: 13, 113 💬 |
355 |
Sunphenon egcg |
Epigallocatechin gallate |
- |
- |
- |
013 3件: 13, 17, 113 💬 |
356 |
Sustanon |
- |
- |
- |
- |
113 1件: 113 💬 |
357 |
Sustanon (testosterone) |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 1件: 113 💬 |
358 |
Sustanon 250 |
- |
- |
- |
- |
113 1件: 113 💬 |
359 |
Suvodirsen |
- |
- |
- |
- |
113 1件: 113 💬 |
360 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
361 |
Tadalafil |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 7件: 6 , 51, 75, 84, 86, 113, 210 💬 |
362 |
Tadalafil 20 mg |
Tadalafil |
1件: D02008 D02008 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
113 1件: 113 💬 |
363 |
Tadalafil and sildenafil |
Sildenafil |
3件: D02008 D02008, D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
113 1件: 113 💬 |
364 |
Tamox |
- |
- |
- |
- |
113 1件: 113 💬 |
365 |
Tamoxifen |
Tamoxifen |
2件: D00966 D00966, D08559 D08559 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
002 4件: 2 , 86, 113, 227 💬 |
366 |
Tamoxifen 20mg hexal® filmtabletten |
Tamoxifen |
2件: D00966 D00966, D08559 D08559 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
113 1件: 113 💬 |
367 |
Tamoxifen citrate |
Tamoxifen |
2件: D00966 D00966, D08559 D08559 💬 |
ESR1 2件: ESR1, ESR2 💬 |
Breast cancer 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway |
113 1件: 113 💬 |
368 |
Tas-205 |
- |
- |
- |
- |
113 1件: 113 💬 |
369 |
Tehalose 30gr |
- |
- |
- |
- |
113 1件: 113 💬 |
370 |
Temerit |
- |
- |
- |
- |
113 1件: 113 💬 |
371 |
Testosterone |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
001 8件: 1 , 2 , 3 , 13, 60, 78, 113, 265 💬 |
372 |
Testosterone decanoate |
Testosterone |
7件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087, D08573 D08573 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 1件: 113 💬 |
373 |
Testosterone enanthate |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 1件: 113 💬 |
374 |
Testosterone isocaproate |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 1件: 113 💬 |
375 |
Testosterone phenylpropionate |
Testosterone |
7件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087, D08574 D08574 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 1件: 113 💬 |
376 |
Testosterone propionate |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
113 1件: 113 💬 |
377 |
Tetracosactide |
Tetracosactide |
1件: D00284 D00284 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
083 4件: 83, 113, 145, 222 💬 |
378 |
Tetracosactide hexaacetate |
Tetracosactide |
1件: D00284 D00284 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
113 1件: 113 💬 |
379 |
Tideglusib |
Tideglusib |
- |
- |
- |
005 2件: 5 , 113 💬 |
380 |
Tinset |
- |
- |
- |
- |
113 1件: 113 💬 |
381 |
Tranilast |
Tranilast |
1件: D02027 D02027 💬 |
- |
- |
046 4件: 46, 84, 106, 113 💬 |
382 |
Translarna |
- |
- |
- |
- |
113 1件: 113 💬 |
383 |
Translarna 1000 mg granules for oral suspension |
- |
- |
- |
- |
113 1件: 113 💬 |
384 |
Translarna 125 mg granules for oral suspension |
- |
- |
- |
- |
113 1件: 113 💬 |
385 |
Translarna 250 mg granules for oral suspension |
- |
- |
- |
- |
113 1件: 113 💬 |
386 |
Treatment phase group 4 |
- |
- |
- |
- |
113 1件: 113 💬 |
387 |
Trehalose |
Trehalose |
- |
- |
- |
113 1件: 113 💬 |
388 |
Triatec |
- |
- |
- |
- |
113 1件: 113 💬 |
389 |
Umbilical cord mesenchymal stem cell |
- |
- |
- |
- |
113 1件: 113 💬 |
390 |
Umbilical cord mesenchymal stem cells |
- |
- |
- |
- |
013 5件: 13, 46, 57, 97, 113 💬 |
391 |
Vamarolone |
- |
- |
- |
- |
113 1件: 113 💬 |
392 |
Vamorolone |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 2件: 97, 113 💬 |
393 |
Vamorolone 0.25 mg/day/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
394 |
Vamorolone 0.25 mg/kg/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
395 |
Vamorolone 0.75 mg/day/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
396 |
Vamorolone 0.75 mg/kg/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
397 |
Vamorolone 2.0 mg/day/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
398 |
Vamorolone 2.0 mg/kg/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
399 |
Vamorolone 6.0 mg/day/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
400 |
Vamorolone 6.0 mg/kg/day |
Vamorolone |
1件: D11000 D11000 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
113 1件: 113 💬 |
401 |
Vbp15 |
- |
- |
- |
- |
113 1件: 113 💬 |
402 |
Viltolarsen |
Viltolarsen |
1件: D11528 D11528 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
403 |
Vit c vit e zn se |
- |
- |
- |
- |
113 1件: 113 💬 |
404 |
Wve-210201 |
- |
- |
- |
- |
113 1件: 113 💬 |
405 |
Wve-210201 (suvodirsen) |
- |
- |
- |
- |
113 1件: 113 💬 |
406 |
Xeomin |
- |
- |
- |
- |
005 7件: 5 , 6 , 7 , 13, 15, 17, 113 💬 |
407 |
Zn |
- |
- |
- |
- |
113 2件: 113, 299 💬 |